4
Changes in Ownership
Pacira BioSciences, Inc. Filed Acc 0001396814-25-000030
Chief Commercial Officer acquired 54,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan Chief Commercial Officer | 2025-02-01 | Grant or award | +54,000 | 54,000 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Teehan Brendan Chief Commercial Officer | 2025-02-04 | Grant or award · Stock Option (Right to Buy) | +99,500 | $26.59 | $2,645,705 | 99,500 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1738711527.xml…